Business Description
Biofil Chemicals & Pharmaceuticals Ltd
SIC : 2834
ISIN : INE829A01014
Total Employee Number:
26Compare
Compare
Traded in other countries / regions
524396.India IPO Date
1994-02-10Description
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical and specialty chemicals company operating through two divisions: a Pharmaceutical Division and a Chemicals Division. It manufactures and trades pharmaceutical products and also provides job work services for the manufacturing of pharmaceutical drugs. Its product range includes sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumarate, micro crystalline cellulose, and dicyclomine hydrochloride. The company serves pharmaceutical manufacturers and chemical buyers, with the Pharmaceutical segment contributing the majority of revenue. Its operations are based in India, where it produces and supplies active pharmaceutical ingredients, excipients, and related chemical intermediates to domestic customers. Revenue is generated primarily through product sales and contract manufacturing or job work arrangements, with the pharma segment accounting for the larger share of total turnover.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.1 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 2.75 | |||||
Interest Coverage | 340 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.95 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.9 | |||||
3-Year EBITDA Growth Rate | 43.4 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year FCF Growth Rate | -87.6 | |||||
3-Year Book Growth Rate | 7.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.88 | |||||
9-Day RSI | 49.61 | |||||
14-Day RSI | 50.31 | |||||
3-1 Month Momentum % | -10.33 | |||||
6-1 Month Momentum % | 3.87 | |||||
12-1 Month Momentum % | -27.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 41.05 | |||||
Days Sales Outstanding | 378.23 | |||||
Days Payable | 308.66 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6.51 | |||||
Operating Margin % | 1.49 | |||||
Net Margin % | 1.41 | |||||
EBITDA Margin % | 3.2 | |||||
FCF Margin % | -2.38 | |||||
OCF Margin % | -1.79 | |||||
ROE % | 2.36 | |||||
ROA % | 0.97 | |||||
ROIC % | 1.42 | |||||
3-Year ROIIC % | -5.62 | |||||
ROC (Joel Greenblatt) % | 3.96 | |||||
ROCE % | 3.92 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 193.3 | |||||
PE Ratio without NRI | 109.53 | |||||
Shiller PE Ratio | 40.23 | |||||
PEG Ratio | 25.47 | |||||
PS Ratio | 1.55 | |||||
PB Ratio | 2.47 | |||||
Price-to-Tangible-Book | 2.48 | |||||
EV-to-EBIT | 64.61 | |||||
EV-to-EBITDA | 48.46 | |||||
EV-to-Revenue | 1.54 | |||||
EV-to-FCF | -69.29 | |||||
Price-to-GF-Value | 0.68 | |||||
Price-to-Projected-FCF | 3.01 | |||||
Price-to-Median-PS-Value | 0.74 | |||||
Price-to-Peter-Lynch-Fair-Value | 12.94 | |||||
Price-to-Graham-Number | 1.46 | |||||
| Price-to-Net-Current-Asset-Value | 3.67 | |||||
Earnings Yield (Greenblatt) % | 1.55 | |||||
FCF Yield % | -1.52 | |||||
Forward Rate of Return (Yacktman) % | 4.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biofil Chemicals & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 343.129 | ||
| EPS (TTM) (₹) | 0.298 | ||
| Beta | 1.5229 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.45 | ||
| Volatility % | 44.64 | ||
| 14-Day RSI | 50.31 | ||
| 14-Day ATR (₹) | 2.498387 | ||
| 20-Day SMA (₹) | 32.6565 | ||
| 12-1 Month Momentum % | -27.65 | ||
| 52-Week Range (₹) | 25.6 - 46.82 | ||
| Shares Outstanding (Mil) | 16.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biofil Chemicals & Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biofil Chemicals & Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biofil Chemicals & Pharmaceuticals Ltd Frequently Asked Questions
What is Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396)'s stock price today?
The current price of BOM:524396 is ₹32.86. The 52 week high of BOM:524396 is ₹46.82 and 52 week low is ₹25.60.
When is next earnings date of Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396)?
The next earnings date of Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396) is .
Does Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396) pay dividends? If so, how much?
Biofil Chemicals & Pharmaceuticals Ltd(BOM:524396) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers